Heart health in New Zealand

Robert Beaglehole1, Ruth Bonita

  • 1University of Auckland, Auckland, New Zealand. r.beaglehole@auckland.ac.nz

Insights

Cardiovascular disease (CVD) death rates in New Zealand have significantly decreased due to improved risk factor management. Future efforts must address rising burdens in vulnerable populations and promote health equity, particularly reducing tobacco use among Maori and Pacific Islanders.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Global health faces a growing burden from chronic diseases like cardiovascular diseases (CVD), cancer, chronic respiratory diseases, and diabetes.
  • New Zealand has experienced a remarkable decline exceeding 60% in cardiovascular disease death rates since the late 1960s.
  • This decline is largely attributed to positive shifts in key cardiovascular risk factors within the population.

Purpose of the Study:

  • To analyze the trends in cardiovascular disease mortality in New Zealand.
  • To identify the primary drivers behind the observed decline in cardiovascular disease deaths.
  • To outline critical challenges and strategic approaches for future cardiovascular disease prevention and health equity.

Main Methods:

  • Analysis of national mortality data for cardiovascular diseases in New Zealand.
  • Examination of trends in major cardiovascular risk factors over several decades.
  • Identification of demographic and socioeconomic groups facing a disproportionate burden of cardiovascular disease.

Main Results:

  • A significant reduction in cardiovascular disease death rates has been achieved in New Zealand.
  • Favorable trends in major cardiovascular risk factors are the principal contributors to this mortality decline.
  • Anticipated increases in cardiovascular disease burden among the elderly, Maori, and economically disadvantaged populations are projected.

Conclusions:

  • Implementing a comprehensive public health strategy is crucial for sustained vascular disease prevention and control.
  • Reducing overall population risk and targeting high-risk individuals are essential components of this strategy.
  • Promoting health equity, specifically through rapid tobacco use reduction in Maori and Pacific Island communities, is a key priority for New Zealand.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...